Table 1.
Characteristics | Patient number | T1/T2 | AD/SCC | Hb: ≥/< 13.1g/dL | Pulmonary function: normal/impaired |
---|---|---|---|---|---|
Age (years) | |||||
≥76 | 50 | 32/18 | 32/18 | 25/25 | 13/27 |
<76 | 41 | 28/13 | 30/11 | 21/20 | 17/34 |
Gender | |||||
Male | 65 | 39/26 | 39/26 | 39/26 | 16/49 |
Female | 26 | 21/5 | 23/3 | 7/19 | 14/12 |
Performance status | |||||
0 | 38 | 27/11 | 29/9 | 18/20 | 14/24 |
1 | 45 | 27/18 | 29/16 | 23/22 | 15/30 |
2 | 8 | 6/2 | 4/4 | 5/3 | 1/7 |
T stage | |||||
T1 | 60 | – | 42/18 | 29/31 | 21/39 |
T2 | 31 | – | 20/11 | 17/14 | 9/22 |
Histology | |||||
AD | 62 | 42/20 | – | 29/33 | 22/40 |
SCC | 29 | 18/11 | – | 17/12 | 8/21 |
Hb (g/dL) | |||||
Median (range) | 13.1 (9.1–18.3) | ||||
≥13.1 | 46 | 29/17 | 29/17 | – | 9/37 |
<13.1 | 45 | 31/14 | 33/12 | – | 21/24 |
Pulmonary function | |||||
Normal | 30 | 21/9 | 24/6 | 9/21 | – |
Impaired | 61 | 39/22 | 38/23 | 37/24 | – |
AD, adenocarcinoma; Hb, hemoglobin; SCC, squamous cell carcinoma;
–, not applicable.